Twist Bioscience Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.9% | +1.6% | 0.0% | -19.8% | -4.1% | +0.4% | -5.3% | -1.0% | +3.2% | +3.6% | +5.7% | – | |
| – | -6.2% | +25.4% | -0.7% | -10.1% | -2.9% | +69.5% | -21.0% | +0.2% | -17.5% | +42.7% | -4.0% | – | |
| – | +20.6% | +549.8% | +263.4% | -109.1% | – | – | – | -284.6% | – | – | +106.5% | – | |
| – | -37.1% | -60.0% | +60.0% | +107.5% | +13.3% | +82.7% | +121.2% | +35.6% | -19.7% | -19.9% | +21.0% | – | |
| – | – | -225.8% | -86.4% | +80.7% | +19.5% | -7.2% | +559.0% | +32.0% | -19.9% | +27.9% | -19.7% | – | |
| – | +114.5% | -36.6% | -99.5% | +14.3% | -25.0% | -16.7% | -40.0% | -33.3% | +0.0% | +300.0% | -25.0% | – | |
| – | -433.3% | – | +59.1% | +24.7% | +394.7% | -82.2% | -42.9% | +205.3% | -94.7% | +1,288.6% | -8.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.